Article Details

FDA Grants Fast-Track Designation to Pfizer and Vivet Therapeutics for Treatment of Wilson Disease

Retrieved on: 2021-08-12 19:29:03

Tags for this article:

Click the tags to see associated articles and topics

FDA Grants Fast-Track Designation to Pfizer and Vivet Therapeutics for Treatment of Wilson Disease. View article details on hiswai:

Excerpt

... fast-track designation to VTX-801, a gene therapy developed by clinical-stage biotechnology company Vivet Therapeutics in conjunction with Pfizer, ...

Article found on: www.biopharminternational.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up